Synaptogenix Stock Beta
| SNPX Stock | USD 4.71 0.05 1.05% |
Synaptogenix fundamentals help investors to digest information that contributes to Synaptogenix's financial success or failures. It also enables traders to predict the movement of Synaptogenix Stock. The fundamental analysis module provides a way to measure Synaptogenix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Synaptogenix stock.
Synaptogenix | Beta |
Synaptogenix Company Beta Analysis
Synaptogenix's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Synaptogenix Beta | 1.51 |
Most of Synaptogenix's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Synaptogenix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Synaptogenix Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Synaptogenix is extremely important. It helps to project a fair market value of Synaptogenix Stock properly, considering its historical fundamentals such as Beta. Since Synaptogenix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Synaptogenix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Synaptogenix's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Synaptogenix has a Beta of 1.507. This is 75.23% higher than that of the Biotechnology sector and 8.42% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Synaptogenix Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Synaptogenix's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Synaptogenix could also be used in its relative valuation, which is a method of valuing Synaptogenix by comparing valuation metrics of similar companies.Synaptogenix is currently under evaluation in beta category among related companies.
Synaptogenix ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Synaptogenix's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Synaptogenix's managers, analysts, and investors.Environmental | Governance | Social |
Synaptogenix Institutional Holders
Institutional Holdings refers to the ownership stake in Synaptogenix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Synaptogenix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Synaptogenix's value.| Shares | Hayek Kallen Investment Management | 2023-12-31 | 17.5 K | Elevated Capital Advisors, Llc | 2023-12-31 | 15.9 K | Advisor Group Holdings, Inc. | 2023-12-31 | 3.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.3 K | Orion Capital Management Llc | 2023-12-31 | 2 K | Ubs Group Ag | 2023-12-31 | 1.8 K | Blackrock Inc | 2023-12-31 | 942 | Acadian Asset Management Llc | 2023-12-31 | 591 | Tower Research Capital Llc | 2023-12-31 | 386 | Renaissance Technologies Corp | 2023-12-31 | 540.9 K | Geode Capital Management, Llc | 2023-12-31 | 154.5 K |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Synaptogenix will likely underperform.
Synaptogenix Fundamentals
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | (23.9 M) | ||||
| Shares Outstanding | 1.09 M | ||||
| Shares Owned By Insiders | 2.43 % | ||||
| Shares Owned By Institutions | 3.92 % | ||||
| Number Of Shares Shorted | 30.18 K | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.31 M) | ||||
| Net Income | (6.04 M) | ||||
| Cash And Equivalents | 28.75 M | ||||
| Cash Per Share | 4.20 X | ||||
| Current Ratio | 47.22 X | ||||
| Book Value Per Share | 25.27 X | ||||
| Cash Flow From Operations | (5.17 M) | ||||
| Short Ratio | 0.38 X | ||||
| Earnings Per Share | (29.50) X | ||||
| Target Price | 14.0 | ||||
| Beta | 1.51 | ||||
| Market Capitalization | 4.96 M | ||||
| Total Asset | 31.11 M | ||||
| Retained Earnings | (33.61 M) | ||||
| Working Capital | 26.26 M | ||||
| Net Asset | 31.11 M |
About Synaptogenix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synaptogenix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synaptogenix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synaptogenix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Synaptogenix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Synaptogenix's short interest history, or implied volatility extrapolated from Synaptogenix options trading.
Currently Active Assets on Macroaxis
When determining whether Synaptogenix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synaptogenix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synaptogenix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synaptogenix Stock:Check out Synaptogenix Piotroski F Score and Synaptogenix Altman Z Score analysis. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Synaptogenix Stock analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Synaptogenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synaptogenix. If investors know Synaptogenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synaptogenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.50) | Return On Assets (0.15) | Return On Equity (0.20) |
The market value of Synaptogenix is measured differently than its book value, which is the value of Synaptogenix that is recorded on the company's balance sheet. Investors also form their own opinion of Synaptogenix's value that differs from its market value or its book value, called intrinsic value, which is Synaptogenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synaptogenix's market value can be influenced by many factors that don't directly affect Synaptogenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synaptogenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Synaptogenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synaptogenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.